Last Sunday I started my day in the bathroom staring at a needle. I took that needle and stuck it in my partner's arm. (It’s not what you think it is)
A few seconds before, she had done the same to me. After that we used our phones to scan and sync our needles to an app. To be accurate, we synced with a monitor on top of the needle. This device will monitor and display our glucose levels live for the next 14 days.
We are both experimenting with our diet and routines. We want to know what is good for us and what it is best to avoid. We are not alone doing so.
There are millions of people experimenting and trying out various things with the goal of longevity. This is a story as old as the sun. But now, there's a tectonic shift happening.
Even before Hippocrates, medicine was (and still is) kinda generic. One treatment for many. Now, affordable wearables, Big Data, and AI unlock the potential for personalised solutions.
A new technology in the wearables space is going to get us one step closer to that future.
Continuous Glucose Monitors (CGMs) are about to breakout.
Let's take a deep dive into the landscape.
First of all let's check Google Trends to understand if it is a growing or a declining market.
Clearly, awareness is rising. But what is the the market size?
According to Mordor Intelligence the CGM market size in 2024 is estimated at $11.6 Billion with a compound annual growth rate of 12.89%. Meaning that they are forecasting a market size of around $21 Billion in 2029. These are huge numbers.
Keep in mind, these numbers include people with diabetes. However, our focus is on non-diabetics who want to optimize their health. It also has to be said that developments from the wellbeing area will have positive developments for the diabetes market.
From the same report: "As per the International Diabetes Federation (IDF), Africa is projected to witness a 134% surge in the diabetic population from 2021 to 2045, whereas North America and the Caribbean are expected to experience a 24% increase in the disease population. By 2045, China is likely to have the highest number of individuals affected by diabetes globally."